Frequently Asked Questions
The market is segmented based on , By type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, others), End Users (Hospitals and Clinics, Academic and Research, Others), Application (Hospitals and Clinics, Academic and Research) - Industry Trends and Forecast to 2030.
.
The Global Human Rotavirus Vaccine Market size was valued at USD 7.20 USD million in 2022.
The Global Human Rotavirus Vaccine Market is projected to grow at a CAGR of 6.2% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.
